{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:34:24Z","timestamp":1793316864574,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejphar.2021.174593","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T21:29:51Z","timestamp":1640899791000},"page":"174593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["A Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies"],"prefix":"10.1016","volume":"916","author":[{"given":"Kimia","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5837-6148","authenticated-orcid":false,"given":"Kosar","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174593_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.humpath.2017.02.011","article-title":"Doxycycline-induced gastrointestinal injury","volume":"66","author":"Affolter","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ejphar.2021.174593_bib2","first-page":"1617","article-title":"Doxycycline as potential anti-cancer agent","volume":"17","author":"Ali","year":"2017","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174593_bib3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/ph14090852","article-title":"Doxycycline attenuates cancer cell growth by suppressing NLRP3-mediated inflammation","volume":"14","author":"Alsaadi","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2021.174593_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1289\/ehp.1408524","article-title":"Effects of benzo [a] pyrene exposure on human hepatocellular carcinoma cell angiogenesis, metastasis, and NF-\u03ba B signaling","volume":"123","author":"Ba","year":"2015","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejphar.2021.174593_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10456-011-9207-3","article-title":"Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma","volume":"14","author":"Bausch","year":"2011","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejphar.2021.174593_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ni.2060","article-title":"Inflammation meets cancer, with NF-\u03baB as the matchmaker","volume":"12","author":"Ben-Neriah","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2021.174593_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2021.174593_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174593_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4236\/jct.2015.610093","article-title":"Cancer therapy using antibiotics","volume":"6","author":"Bhattacharya","year":"2015","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.ejphar.2021.174593_bib10","first-page":"874","article-title":"Doxycycline","volume":"129","author":"Bonnetblanc","year":"2002","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.ejphar.2021.174593_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2340\/00015555-2566","article-title":"Development of papulopustular rosacea during nivolumab therapy of metastatic cancer","volume":"97","author":"Bousquet","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ejphar.2021.174593_bib12","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41423-020-00570-y","article-title":"CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape","volume":"18","author":"Chen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2021.174593_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jac\/29.3.245","article-title":"Tetracyclines, molecular and clinical aspects","volume":"29","author":"Chopra","year":"1992","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejphar.2021.174593_bib14","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/AAC.00594-16","article-title":"rRNA binding sites and the molecular mechanism of action of the tetracyclines","volume":"60","author":"Chukwudi","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2021.174593_bib15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jaad.2018.10.062","article-title":"Inflammatory eruptions associated with immune checkpoint inhibitor therapy: a single-institution retrospective analysis with stratification of reactions by toxicity and implications for management","volume":"80","author":"Coleman","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejphar.2021.174593_bib17","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1073\/pnas.1018866109","article-title":"Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia","volume":"109","author":"Conley","year":"2012","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejphar.2021.174593_bib18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ccr.2013.03.022","article-title":"Mutant p53 prolongs NF-\u03baB activation and promotes chronic inflammation and inflammation-associated colorectal cancer","volume":"23","author":"Cooks","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2021.174593_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","article-title":"Revisiting doxycycline in pregnancy and early childhood\u2013time to rebuild its reputation?","volume":"15","author":"Cross","year":"2016","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2021.174593_bib20","doi-asserted-by":"crossref","first-page":"67269","DOI":"10.18632\/oncotarget.18428","article-title":"Vitamin C and Doxycycline: a synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)","volume":"8","author":"De Francesco","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174593_bib21","doi-asserted-by":"crossref","first-page":"56126","DOI":"10.18632\/oncotarget.18445","article-title":"Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: implications for optimizing anti-angiogenic therapy","volume":"8","author":"De Francesco","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174593_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2018.10.030","article-title":"NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver","volume":"442","author":"Deng","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2021.174593_bib23","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/cncr.31978","article-title":"Targeting autophagy using natural compounds for cancer prevention and therapy","volume":"125","author":"Deng","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2021.174593_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-61381-9","article-title":"Mitochondria as target to inhibit proliferation and induce apoptosis of cancer cells: the effects of doxycycline and gemcitabine","volume":"10","author":"Dijk","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174593_bib26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","article-title":"Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis","volume":"15","author":"Ebos","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2021.174593_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/14712598.2018.1445222","article-title":"Results and challenges of immune checkpoint inhibitors in colorectal cancer","volume":"18","author":"Emambux","year":"2018","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.ejphar.2021.174593_bib28","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1096\/fj.08-110494","article-title":"Doxycycline induces membrane expression of VE\u2010cadherin on endothelial cells and prevents vascular hyperpermeability","volume":"22","author":"Fainaru","year":"2008","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2021.174593_bib29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.174593_bib30","first-page":"2202","article-title":"Doxycycline, Azithromycin and Vitamin C (DAV): a potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs)","volume":"11","author":"Fiorillo","year":"2019","journal-title":"Aging (N Y)"},{"key":"10.1016\/j.ejphar.2021.174593_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbcan.2008.02.001","article-title":"Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses","volume":"1785","author":"Guo","year":"2008","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejphar.2021.174593_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13569-020-00128-6","article-title":"The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review","volume":"10","author":"Hadjimichael","year":"2020","journal-title":"Clin. Sarcoma Res."},{"key":"10.1016\/j.ejphar.2021.174593_bib33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejca.2016.02.025","article-title":"Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy","volume":"60","author":"Hofmann","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2021.174593_bib34","doi-asserted-by":"crossref","first-page":"37377","DOI":"10.18632\/oncotarget.16343","article-title":"NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway","volume":"8","author":"Jana","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174593_bib35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-\u03baB: linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2021.174593_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.micinf.2007.12.004","article-title":"Natural death of adult Onchocerca volvulus and filaricidal effects of doxycycline induce local FOXP3+\/CD4+ regulatory T cells and granzyme expression","volume":"10","author":"Korten","year":"2008","journal-title":"Microb. Infect."},{"key":"10.1016\/j.ejphar.2021.174593_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3835(84)80023-3","article-title":"The mitochondrial genetic system as a target for chemotherapy: tetracyclines as cytostatics","volume":"25","author":"Kroon","year":"1984","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2021.174593_bib38","article-title":"Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174593_bib39","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/bjc.2017.378","article-title":"Tetracycline use and risk of incident skin cancer: a prospective study","volume":"118","author":"Li","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2021.174593_bib40","first-page":"3041","article-title":"Doxycycline targets aldehyde dehydrogenase-positive breast cancer stem cells","volume":"39","author":"Lin","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2021.174593_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/284067a0","article-title":"Metastatic potential correlates with enzymatic degradation of basement membrane collagen","volume":"284","author":"Liotta","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.174593_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bpg.2018.05.010","article-title":"Colorectal cancer prevention in patients with ulcerative colitis","volume":"32","author":"Lopez","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.ejphar.2021.174593_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.29798","article-title":"Basolateral CD147 induces hepatocyte polarity loss by E\u2010cadherin ubiquitination and degradation in hepatocellular carcinoma progress","volume":"68","author":"Lu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2021.174593_bib44","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","article-title":"Colorectal cancer chemotherapy: the evolution of treatment and new approaches","volume":"24","author":"McQuade","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174593_bib45","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s13277-013-0734-y","article-title":"Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians","volume":"34","author":"Malhotra","year":"2013","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ejphar.2021.174593_bib46","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.bmcl.2019.04.045","article-title":"Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs","volume":"29","author":"Markowska","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2021.174593_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.gde.2008.12.003","article-title":"Cancer stem cells: a model in the making","volume":"19","author":"Marotta","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ejphar.2021.174593_bib48","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.18632\/oncotarget.23397","article-title":"Pro-apoptotic effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by C. burnetii","volume":"9","author":"Melenotte","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174593_bib49","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1158\/1535-7163.MCT-13-1060","article-title":"Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma","volume":"13","author":"Meng","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2021.174593_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151539","article-title":"Doxycycline promotes carcinogenesis & metastasis via chronic inflammatory pathway: an in vivo approach","volume":"11","author":"Nanda","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174593_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lab.2003.12.012","article-title":"Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells","volume":"143","author":"Onoda","year":"2004","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ejphar.2021.174593_bib52","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/ijc.21447","article-title":"Tetracycline analogues (doxycycline and COL\u20103) induce caspase\u2010dependent and\u2010independent apoptosis in human colon cancer cells","volume":"118","author":"Onoda","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2021.174593_bib53","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"P\u00e0ez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2021.174593_bib54","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1039\/C4MD00556B","article-title":"Evaluation of the anti-inflammatory\/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures","volume":"6","author":"Panico","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejphar.2021.174593_bib55","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5217\/ir.2018.16.3.338","article-title":"Intestinal microbiota, chronic inflammation, and colorectal cancer","volume":"16","author":"Park","year":"2018","journal-title":"Intestinal research"},{"key":"10.1016\/j.ejphar.2021.174593_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-018-0710-0","article-title":"Targeting cellular metabolism using rapamycin and\/or doxycycline enhances anti-tumour effects in human glioma cells","volume":"18","author":"Pet\u0151v\u00e1ri","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2021.174593_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","article-title":"Emerging roles of caspase-3 in apoptosis","volume":"6","author":"Porter","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2021.174593_bib58","first-page":"3971","article-title":"Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study","volume":"29","author":"Raimondi","year":"2021","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejphar.2021.174593_bib59","first-page":"1","article-title":"Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study","author":"Raimondi","year":"2021","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejphar.2021.174593_bib60","series-title":"Preemptive Therapy of Cetuximab-Induced Skin Rash Using Doxycycline, Sunscreen, Hydrocortisone, and Moisturizer in Colorectal and Head and Neck Cancer Patients","author":"Redman","year":"2015"},{"key":"10.1016\/j.ejphar.2021.174593_bib61","doi-asserted-by":"crossref","first-page":"104790","DOI":"10.1016\/j.tiv.2020.104790","article-title":"Cytotoxic and proapoptotic effect of doxycycline\u2013An in vitro study on the human skin melanoma cells","volume":"65","author":"Rok","year":"2020","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejphar.2021.174593_bib62","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2021.174593_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7819-7-2","article-title":"Does Doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?","volume":"7","author":"Sagar","year":"2009","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ejphar.2021.174593_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-10-31","article-title":"Lowering the apoptotic threshold in colorectal cancer cells by targeting mitochondria","volume":"10","author":"Sagar","year":"2010","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2021.174593_bib65","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fonc.2018.00452","article-title":"Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients: a clinical pilot study","volume":"8","author":"Scatena","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2021.174593_bib66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2021.174593_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192717","article-title":"Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators","volume":"13","author":"Schmidt","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174593_bib68","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.oraloncology.2009.11.013","article-title":"Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma\u2013in vitro and in vivo studies","volume":"46","author":"Shen","year":"2010","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejphar.2021.174593_bib69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molmed.2015.04.001","article-title":"EGFR and NF-\u03baB: partners in cancer","volume":"21","author":"Shostak","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174593_bib70","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/CCO.0000000000000290","article-title":"Dermatologic complications of anti-PD-1\/PD-L1 immune checkpoint antibodies","volume":"28","author":"Sibaud","year":"2016","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.ejphar.2021.174593_bib71","doi-asserted-by":"crossref","first-page":"S326","DOI":"10.1016\/j.ymthe.2006.08.930","article-title":"844. A single vector-dependent, doxycycline-regulatable, lung cancer specific oncolytic adenovirus","volume":"13","author":"Sipo","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2021.174593_bib72","series-title":"The Tetracyclines, Mayo Clinic Proceedings","first-page":"727","author":"Smilack","year":"1999"},{"key":"10.1016\/j.ejphar.2021.174593_bib73","first-page":"3995","article-title":"Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells","volume":"29","author":"Son","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2021.174593_bib74","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2009.05.004","article-title":"Doxycycline inhibits the adhesion and migration of melanoma cells by inhibiting the expression and phosphorylation of focal adhesion kinase (FAK)","volume":"285","author":"Sun","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2021.174593_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1757-1626-1-144","article-title":"Doxycycline-induced ulceration mimicking esophageal cancer","volume":"1","author":"Tahan","year":"2008","journal-title":"Cases journal"},{"key":"10.1016\/j.ejphar.2021.174593_bib76","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/gt.2012.96","article-title":"Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination","volume":"20","author":"Tang","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejphar.2021.174593_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0607-x","article-title":"Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-\u03baB activation","volume":"16","author":"Tang","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2021.174593_bib78","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/gt.2008.42","article-title":"Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery","volume":"15","author":"Thorne","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejphar.2021.174593_bib79","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.2017.14155","article-title":"Targeting immune checkpoints in cancer therapy","volume":"318","author":"Topalian","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2021.174593_bib80","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00280-015-2861-1","article-title":"Targeted therapy in cancer","volume":"76","author":"Tsimberidou","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174593_bib81","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00109-013-1045-x","article-title":"NF-\u03baB in colorectal cancer","volume":"91","author":"Vaiopoulos","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174593_bib82","first-page":"129","article-title":"Safety and efficacy of doxycycline in the treatment of rosacea","volume":"2","author":"Valent\u00edn","year":"2009","journal-title":"Clin. Cosmet. Invest. Dermatol.: CCID"},{"key":"10.1016\/j.ejphar.2021.174593_bib83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3835(86)90037-6","article-title":"Inhibition of mitochondrial protein synthesis leads to proliferation arrest in the G1-phase of the cell cycle","volume":"32","author":"van den Bogert","year":"1986","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2021.174593_bib84","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s15010-017-1061-9","article-title":"Case report: Coxiella burnetii vascular infection and lymphoma in The Netherlands","volume":"46","author":"van Roeden","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.ejphar.2021.174593_bib85","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jss.2003.08.167","article-title":"Doxycycline and indomethacin synergistically downregulate beta-catenin signaling and inhibit colon cancer cell growth","volume":"114","author":"Veeramachaneni","year":"2003","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2021.174593_bib86","doi-asserted-by":"crossref","first-page":"35157","DOI":"10.18632\/oncotarget.6038","article-title":"Aspirin, lysine, mifepristone and doxycycline combined can effectively and safely prevent and treat cancer metastasis: prevent seeds from gemmating on soil","volume":"6","author":"Wan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174593_bib87","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317718192","article-title":"Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines","volume":"39","author":"Wang","year":"2017","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ejphar.2021.174593_bib88","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/MCB.19.5.3485","article-title":"Transcriptional cross talk between NF-\u03baB and p53","volume":"19","author":"Webster","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174593_bib89","doi-asserted-by":"crossref","first-page":"13431","DOI":"10.1111\/jcmm.15966","article-title":"Doxorubicin hydrochloride enhanced antitumour effect of CEA\u2010regulated oncolytic virotherapy in live cancer cells and a mouse model","volume":"24","author":"Xiao","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174593_bib90","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/biomedicines8120593","article-title":"Oncolytic adenovirus CD55-smad4 suppresses cell proliferation, metastasis, and tumor stemness in colorectal cancer by regulating wnt\/\u03b2-catenin signaling pathway","volume":"8","author":"Xiao","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2021.174593_bib91","first-page":"1","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transd. Target. Ther."},{"key":"10.1016\/j.ejphar.2021.174593_bib92","first-page":"505","article-title":"Induction of apoptotic cell death and in vivo growth inhibition of human cancer cells by a saturated branched-chain fatty acid, 13-methyltetradecanoic acid","volume":"60","author":"Yang","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2021.174593_bib93","article-title":"Doxycycline induces apoptosis and inhibits proliferation and invasion of human cervical carcinoma stem cells","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174593_bib94","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s00284-020-02058-4","article-title":"Novel biosynthesis of Copper nanoparticles using zingiber and allium sp. with synergic effect of doxycycline for anticancer and bactericidal activity","volume":"77","author":"Yaqub","year":"2020","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.ejphar.2021.174593_bib95","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/15384101.2016.1241929","article-title":"Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer","volume":"16","author":"Zhang","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2021.174593_bib96","doi-asserted-by":"crossref","first-page":"16829","DOI":"10.18632\/oncotarget.15166","article-title":"Doxycycline directly targets PAR1 to suppress tumor progression","volume":"8","author":"Zhong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174593_bib97","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.174593_bib98","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/abbs\/gmx097","article-title":"Doxycycline synergizes with doxorubicin to inhibit the proliferation of castration-resistant prostate cancer cells","volume":"49","author":"Zhu","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:57:35Z","timestamp":1757977055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921007494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":96,"alternative-id":["S0014299921007494"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174593","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174593"}}